Clinical Impact of Compensatory Hyperinflation of the Nontreated Adjacent Lobe After Bronchoscopic Lung Volume Reduction with Valves.


Journal

International journal of chronic obstructive pulmonary disease
ISSN: 1178-2005
Titre abrégé: Int J Chron Obstruct Pulmon Dis
Pays: New Zealand
ID NLM: 101273481

Informations de publication

Date de publication:
2022
Historique:
received: 03 03 2022
accepted: 09 06 2022
entrez: 11 7 2022
pubmed: 12 7 2022
medline: 14 7 2022
Statut: epublish

Résumé

Bronchoscopic lung volume reduction (BLVR) with endobronchial valves (EBV) can be a successful treatment for end-stage emphysema patients. The reduction of hyperinflation enhances ventilatory mechanics and diaphragm function. Understanding predictors for treatment success is crucial for further improvements. The aim of this study was to assess the effect of the target lobe volume reduction (TLVR) in relation to the ipsilateral lung volume reduction (ILVR), affected by the compensatory expansion of the adjacent lobe, on the outcome after BLVR with valves. The volumetric relationship of ILVR% to TLVR%, addressed as Patients with a smaller Extensive compensatory hyperinflation of the adjacent non-treated lobe after BLVR results in decreased ILVR, which is responsible for a lack of meaningful improvements in ventilatory mechanics and clinical outcome, despite technically successful lobe volume reduction.

Sections du résumé

Background
Bronchoscopic lung volume reduction (BLVR) with endobronchial valves (EBV) can be a successful treatment for end-stage emphysema patients. The reduction of hyperinflation enhances ventilatory mechanics and diaphragm function. Understanding predictors for treatment success is crucial for further improvements.
Purpose
The aim of this study was to assess the effect of the target lobe volume reduction (TLVR) in relation to the ipsilateral lung volume reduction (ILVR), affected by the compensatory expansion of the adjacent lobe, on the outcome after BLVR with valves.
Patients and Methods
The volumetric relationship of ILVR% to TLVR%, addressed as
Results
Patients with a smaller
Conclusion
Extensive compensatory hyperinflation of the adjacent non-treated lobe after BLVR results in decreased ILVR, which is responsible for a lack of meaningful improvements in ventilatory mechanics and clinical outcome, despite technically successful lobe volume reduction.

Identifiants

pubmed: 35811743
doi: 10.2147/COPD.S364448
pii: 364448
pmc: PMC9257092
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1523-1536

Informations de copyright

© 2022 Wienker et al.

Déclaration de conflit d'intérêts

KD has received speaker fees from Olympus, Boston Scientific, Broncus Medical, Erbe, Böhringer I., Storz; consultant activities at bess, Boston Scientific, Broncus Medical, Fujifilm, FreeFlow, Storz, PulmonX, Böhringer I., Morair Medtech, Medtronic; research grants from Pulmonx, PneumRx, Nuveira, Epigenomics, Broncus, Novartis, Roche, Ambu, Gala Therapeutics. All other authors have no potential conflict of interest.

Références

Eur Respir J. 2014 Feb;43(2):387-96
pubmed: 23845721
Proc Am Thorac Soc. 2008 May 1;5(4):416-20
pubmed: 18453348
N Engl J Med. 2015 Dec 10;373(24):2325-35
pubmed: 26650153
Lancet. 2015 Sep 12;386(9998):1066-73
pubmed: 26116485
Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619866101
pubmed: 31373259
Int J Chron Obstruct Pulmon Dis. 2018 Feb 01;13:465-472
pubmed: 29440884
Eur Radiol. 2012 Jul;22(7):1547-55
pubmed: 22466511
Am J Respir Crit Care Med. 2017 Dec 15;196(12):1535-1543
pubmed: 28885054
Respiration. 2014;87(6):485-91
pubmed: 24800814
Eur Respir J. 2008 Dec;32(6):1443-50
pubmed: 18684848
J Clin Epidemiol. 2008 Feb;61(2):102-9
pubmed: 18177782
N Engl J Med. 2010 Sep 23;363(13):1233-44
pubmed: 20860505
COPD. 2005 Mar;2(1):111-24
pubmed: 17136971
Respirology. 2018 Mar;23(3):306-310
pubmed: 28913877
Spine J. 2007 Sep-Oct;7(5):541-6
pubmed: 17448732
Respiration. 2014;87(6):513-21
pubmed: 24777292
Am J Respir Crit Care Med. 2002 Jan 1;165(1):34-40
pubmed: 11779727
Respiration. 2015;90(4):314-20
pubmed: 26340540
Am J Respir Crit Care Med. 2016 Nov 1;194(9):1073-1082
pubmed: 27580428
Expert Rev Respir Med. 2020 Dec;14(12):1235-1247
pubmed: 32842819
Arch Phys Med Rehabil. 2010 Feb;91(2):221-5
pubmed: 20159125
Eur Respir J. 2012 Nov;40(5):1137-41
pubmed: 22441742

Auteurs

Johannes Wienker (J)

Department of Pneumology, University Medicine Essen- Ruhrlandklinik, Essen, Nordrhein-Westfalen, Germany.

Kaid Darwiche (K)

Department of Pneumology, University Medicine Essen- Ruhrlandklinik, Essen, Nordrhein-Westfalen, Germany.

Julia Wälscher (J)

Department of Pneumology, University Medicine Essen- Ruhrlandklinik, Essen, Nordrhein-Westfalen, Germany.

Jane Winantea (J)

Department of Pneumology, University Medicine Essen- Ruhrlandklinik, Essen, Nordrhein-Westfalen, Germany.

Michael Hagemann (M)

Department of Pneumology, University Medicine Essen- Ruhrlandklinik, Essen, Nordrhein-Westfalen, Germany.

Erik Büscher (E)

Department of Pneumology, University Medicine Essen- Ruhrlandklinik, Essen, Nordrhein-Westfalen, Germany.

Abhinav Singla (A)

Department of Pneumology, University Medicine Essen- Ruhrlandklinik, Essen, Nordrhein-Westfalen, Germany.

Christian Taube (C)

Department of Pneumology, University Medicine Essen- Ruhrlandklinik, Essen, Nordrhein-Westfalen, Germany.

Rüdiger Karpf-Wissel (R)

Department of Pneumology, University Medicine Essen- Ruhrlandklinik, Essen, Nordrhein-Westfalen, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH